Bacitracin Use in Neonates
Bacitracin is not recommended for ophthalmia neonatorum prophylaxis in neonates due to lack of efficacy data and potential nephrotoxicity concerns. 1
Recommendations for Ophthalmia Neonatorum Prophylaxis
- The Centers for Disease Control and Prevention (CDC) specifically recommends against using bacitracin for ophthalmia neonatorum prophylaxis in neonates 1
- Instead, the CDC recommends using one of the following alternatives:
Nephrotoxicity Concerns
- Bacitracin belongs to a class of antibiotics with potential nephrotoxic effects, which is particularly concerning in neonates 2
- Neonates are especially vulnerable to drug-induced kidney injury due to:
Pharmacokinetic Considerations
- When antibiotics must be used in neonates, dosing should be adjusted based on:
- Neonates have physiological differences that affect drug disposition:
Alternative Antibiotic Approaches for Neonatal Infections
For early-onset infections, recommended first-line empirical therapy is:
For late-onset infections, recommended combinations include:
Monitoring and Prevention of Nephrotoxicity
Strategies to prevent acute kidney injury in neonates include:
When using potentially nephrotoxic antibiotics, consider: